
Mortality Risk in Irritable Bowel Syndrome: Results From a Nationwide Prospective Cohort Study
Author(s) -
Kyle Staller,
Ola Olén,
Jonas Söderling,
Björn Roelstraete,
Hans Törnblom,
Hamed Khalili,
Amit D. Joshi,
Long H. Nguyen,
Mingyang Song,
Braden Kuo,
Andrew T. Chan,
Jonas F. Ludvigsson
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/ajg.0000000000000573
Subject(s) - medicine , irritable bowel syndrome , hazard ratio , population , confidence interval , proportional hazards model , cohort study , cohort , confounding , prospective cohort study , environmental health
Mortality concern is a frequent driver of care seeking in patients with irritable bowel syndrome (IBS). Data on mortality in IBS are scarce, and population-based studies have been limited in size. We examined mortality in IBS.